At meeting held on 22 May 2025
The Board of Sun Pharmaceutical Industries at its meeting held on 22 May 2025 has approved appointment of Vidhi Shanghvi (DIN: 06497350) as Whole-time Director for a period of five years, effective from today, i.e., 22 May 2025, which shall be subject to approval of the shareholders at the ensuing Annual General Meeting.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
